VIM and cancer: As clone P2B9 was less capable of forming spheres than parental OPCT-1, this clone appeared to possess a smaller cancer stem/progenitor cell population than the parental cell line from which they were derived, despite being enriched for vimentin-positive, EMT-derived cells.